During the past decade, Manassas Clinical Research Center conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 33 clinical trials were completed, i.e. on average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 24 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Manassas Clinical Research Center" #1 sponsor was "Pfizer" with 6 trials, followed by "Gilead Sciences" with 5 trials sponsored, "Allergan" with 4 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Ionis Pharmaceuticals, Inc." with 4 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Manassas Clinical Research Center" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Cyclerion Therapeutics" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Manassas Clinical Research Center" are "Hypertension" (6 trials), "Diabetes Mellitus, Type 2" (5 trials), "Severe Hypertriglyceridemia" (5 trials), "Diabetes Mellitus" (4 trials) and "Gastroparesis" (4 trials). Many other conditions were trialed in "Manassas Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Manassas Clinical Research Center" are "Drug" (56 trials), "Other" (7 trials), "Biological" (3 trials), "Behavioral" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Relamorelin" (3 trials), "Dapagliflozin" (2 trials), "Darusentan" (2 trials) and "Diet" (2 trials). Other intervention names were less common.

The vast majority of trials in "Manassas Clinical Research Center" are 59 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Manassas Clinical Research Center". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Manassas Clinical Research Center, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Manassas Clinical Research Center, 0 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".